Peritoneal carcinomatosis from ovarian cancer: The role of CT and [ 18F]FDG-PET/CT

Abdominal Imaging

Volumn 35, Issue 6, 2010, Pages 701-707

  Funicelli, L ^a   Travaini, L L ^a   Landoni, F ^a   Trifiro G ^a   Bonello, L ^a   Bellomi, M ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Mesenteric root implant; Multi detector CT; Ovarian cancer; Peritoneal carcinomatosis; Positron emission tomography; Single detector CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODIXANOL;

ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CARCINOMATOUS PERITONITIS; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRUG UPTAKE; FALSE NEGATIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; LAPAROSCOPY; MAJOR CLINICAL STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; OVARY CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE DETECTOR COMPUTED TOMOGRAPHY;

AGED; CARCINOMA; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TRIIODOBENZOIC ACIDS;

EID: 78651230431     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00261-009-9578-8     Document Type: Article

References (29)

1. American Cancer Society (2009) Cancer Facts and Figs 2009. Atlanta, GA: American Cancer Society
2. Johns Hopkins ovarian cancer website. http://ovariancancer.jhmi.edu/menu- understanding.cfm. Accessed 11 September 2009
3. Ozols RF (2005) Treatment goals in ovarian cancer. Int J Gynecol Cancer 5(suppl 1):3-11
4. Meyers MA (1973) Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid. Am J Roentgenol Radium Ther Nucl Med 119:198-206
5. Schwartz PE (2008) Cytoreductive surgery in the management of ovarian cancer. Oncology (Williston Park) 22(9):1025-1033 (discussion 1033-8, 1041,1045)
6. Bristow RE, Tomacruz RS, Armstrong DK, et al. (2002) Survival effects of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta analysis. J Clin Oncol 20:1248-1259
7. Van der Burg ME (2001) Advanced ovarian cancer. Curr Treat Options Oncol 2:109-118
8. Kurtz AB, Tsimikas JV, Tempany CM, et al. (1999) Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis - Report of the Radiology Diagnostic Oncology Group. Radiology 212:19-27
9. Nelson BE, Rosenfield AT, Schwartz PE (1993) Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol 11(1):166-172
10. William MR. Introduction to gynaecologic oncology. www.gyncancer.com/ ovarian-cancer.html. Accessed 11 September 2009
11. Edmonson JH, McCormack GW, Fleming TR, et al. (1985) Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomas. Cancer Treat Rep 69:1243-1248
12. Omura GA, Brady MF, Homesley HD, et al. (1991) Long followup and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. J Clin Oncol 9:1138-1150
13. Griffiths C (1975) Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 42:101-104
14. Boente MP, Chi DS, Hoskins WJ (1998) The role of surgery in the management of ovarian cancer: primary and interval cytoreductive surgery. Semin Oncol 25:326-334
15. Prokopf M, Galanski M (2003) Peritoneal Carcinomatosis and Metastases. Spiral and Multislice Computed Tomography of the Body, vol 16, pp 609-610
16. Forstner R (2007) Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI. Eur Radiol 17(12): 3223-3235 (Epub 2007 Aug)
17. Delbeke D, Martin WH (2001) Positron emission tomography imaging in oncology. Radiol Clin North Am 39(5):883-917
18. Hamacher K, Coenen HH, Stocklin G (1988) Efficient stereospecific synthesis of no-carried-added 2-[18F]-fluoro-2-d-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 29:241-247
19. Holschneider CH, Berek JS (2000) Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 19:3-10
20. Wimberger P, Lehmann N, Kimmig R, et al. (2007) Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Gynecol Oncol 106(1):69-74
21. Turlakow A, Yeung HW, Salmon AS, Macapinlac HA, Larson SM (2003) Peritoneal carcinomatosis: role of (18)F-FDG PET. J Nucl Med 44(9):1407-1412
22. Dromain C, Leboulleux S, Auperin A, et al. (2008) Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT. Abdom Imaging 33:87-93
23. Tempany CM, Zou KH, Silverman SG, et al. (2000) Staging of advanced ovarian cancer: comparison of imaging modalities - report from the Radiology Oncology Group. Radiology 215:761-767
24. Coakley FV, Choi PH, Cougoutas CA, et al. (2002) Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223:495-499
25. Low RN, Chen SC, Barone R (2003) Distinguishing benign from malignant bowel obstruction in patients with malignancy: findings at MR imaging. Radiology 228(1):157-165
26. Fujii S, Matsusue E, Kanasaki Y, et al. (2008) Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol 18(1):18-23 (Epub 2007 Aug 14)
27. Pannu HK, Bristow RE, Cohade C, Fishman EK, Wahl RL (2004) PET-CT in recurrent ovarian cancer: initial observations. Radiographics 24(1):209-223
28. Gadducci A, Cosio S (2009) Surveillance of patients after initial treatment of ovarian cancer. Crit Rev Oncol Hematol [Epub ahead of print]
29. Nakamoto Y, Saga T, Ishimori T, et al. (2001) Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. Am J Roentgenol 176:1449-1454